{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:33:25Z","timestamp":1763642005342},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.prostaglandins.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T17:33:45Z","timestamp":1452533625000},"page":"69-72","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["\u201cAssociation between platelet activating factor acetylhydrolase and diabetic retinopathy: Does inflammation affect the retinal status?\u201d"],"prefix":"10.1016","volume":"122","author":[{"given":"Marilita M.","family":"Moschos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Pantazis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zisis","family":"Gatzioufas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios D.","family":"Panos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gazouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Nitoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Brouzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Jan. 1","key":"10.1016\/j.prostaglandins.2016.01.001_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"Mar. 3","key":"10.1016\/j.prostaglandins.2016.01.001_bib0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Meta-analysis for eye disease (META-EYE) study group. Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"Apr. 4","key":"10.1016\/j.prostaglandins.2016.01.001_bib0015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch. Ophthalmol."},{"issue":"Apr. 4","key":"10.1016\/j.prostaglandins.2016.01.001_bib0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0025","series-title":"Diabetes Mellitus. A Fundamental and Clinical Text","author":"LeRoith","year":"1996"},{"issue":"Mar. 6","key":"10.1016\/j.prostaglandins.2016.01.001_bib0030","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1096\/fasebj.6.6.1312046","article-title":"Platelet-activating factor receptor and signal transduction mechanisms","volume":"6","author":"Shukla","year":"1992","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0035","doi-asserted-by":"crossref","first-page":"17895","DOI":"10.1074\/jbc.272.29.17895","article-title":"Platelet-activating factor acetylhydrolases","volume":"272","author":"Stafforini","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archopht.1991.01080030112049","article-title":"Synthesis of platelet activating factor by ocular tissue from inflamed eyes","volume":"109","author":"Rosenbaum","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0045","first-page":"3327","article-title":"Platelet-activating factor in vasoobliteration of oxygen-induce retinopathy","volume":"43","author":"Beauchamp","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.prostaglandins.2016.01.001_bib0050","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/S0021-9258(18)61336-5","article-title":"Human plasma platelet-activating factor acetylhydrolase. Purification and properties","volume":"262","author":"Stafforini","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prostaglandins.2016.01.001_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1432-1033.1991.tb21066.x","article-title":"Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipase and platelet-activating-factor acetylhydrolase","volume":"200","author":"Aarsman","year":"1991","journal-title":"Eur. J. Biochem."},{"issue":"Nov. 16\u201317","key":"10.1016\/j.prostaglandins.2016.01.001_bib0060","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.clinbiochem.2009.07.023","article-title":"The evaluation of IL-12 concentration, PAF-AH, and PLA (2) activity in patients with type 1 diabetes treated with intensive insulin therapy","volume":"42","author":"Wegner","year":"2009","journal-title":"Clin. Biochem."},{"issue":"Jul. 1","key":"10.1016\/j.prostaglandins.2016.01.001_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.diabres.2009.04.016","article-title":"Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus","volume":"85","author":"Gomes","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"Dec. 1\u20134","key":"10.1016\/j.prostaglandins.2016.01.001_bib0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.prostaglandins.2008.07.001","article-title":"Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes","volume":"87","author":"Gomes","year":"2008","journal-title":"Prostag. Oth. Lipid Mediat."},{"issue":"Dec. 4","key":"10.1016\/j.prostaglandins.2016.01.001_bib0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1582-4934.2002.tb00462.x","article-title":"Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus","volume":"6","author":"Serban","year":"2002","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.prostaglandins.2016.01.001_bib0080","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0024-3205(96)00375-X","article-title":"PAF-acetylhydrolase activity and PAF levels in pancreas and plasma of well-fed, diabetic and fasted rat","volume":"59","author":"Trapali","year":"1996","journal-title":"Life Sci."},{"issue":"Oct. 10","key":"10.1016\/j.prostaglandins.2016.01.001_bib0085","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1194\/jlr.D300021-JLR200","article-title":"Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus","volume":"44","author":"Kujiraoka","year":"2003","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2016.01.001_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0029-1210918","article-title":"Blood platelet behaviour in patients with a type I diabetes mellitus","volume":"94","author":"Spangenberg","year":"1989","journal-title":"Exp. Clin. Endocrinol."},{"issue":"Apr. 4","key":"10.1016\/j.prostaglandins.2016.01.001_bib0095","first-page":"410","article-title":"Action of platelet-activating factor on type 1 diabetic human platelets","volume":"105","author":"Greco","year":"1985","journal-title":"J. Lab. Clin. Med."},{"issue":"Oct. 4","key":"10.1016\/j.prostaglandins.2016.01.001_bib0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0090-6980(00)00082-4","article-title":"Oxidative response and membrane modification of diabetic platelets challenged with PAF","volume":"62","author":"Tiano","year":"2000","journal-title":"Prostag. Oth. Lipid Mediat."},{"issue":"Feb. 2","key":"10.1016\/j.prostaglandins.2016.01.001_bib0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jb\/117.2.425","article-title":"Stimulation of platelet-activating factor synthesis in polymorphonuclear leukocytes from streptozotocin-induced diabetic rats","volume":"117","author":"Akiba","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0110","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1096\/fj.10-160051","article-title":"Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury","volume":"25","author":"Garland","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00296-004-0450-4","article-title":"Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Beh\u00e7et's patients","volume":"25","author":"Tunc","year":"2005","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0120","first-page":"2393","article-title":"Lipid mediators of tumor necrosis factor alpha-induced uveitis","volume":"32","author":"Fleisher","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0125","first-page":"114","article-title":"Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis","volume":"11","author":"Zinchuk","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0130","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1167\/iovs.04-0128","article-title":"Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells","volume":"45","author":"Ma","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0135","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3109\/02713683.2010.513797","article-title":"The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF)","volume":"35","author":"He","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.plefa.2005.02.004","article-title":"New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy","volume":"72","author":"Hardy","year":"2005","journal-title":"Prostag. Leukot Essent Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0145","first-page":"33","article-title":"Effects of PAF-acether on electrophysiological response of isolated retina","volume":"9","author":"Doly","year":"1987","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.prostaglandins.2016.01.001_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(89)90400-7","article-title":"Presence of specific platelet-activating factor binding sites in the rat retina","volume":"163","author":"Thierry","year":"1989","journal-title":"Eur. J. Pharmacol."},{"issue":"Sep. 9","key":"10.1016\/j.prostaglandins.2016.01.001_bib0155","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14728222.2014.930439","article-title":"Correlation of platelet activating factor and age-related macular degeneration","volume":"18","author":"Nitoda","year":"2014","journal-title":"Expert Opin. Ther. Tar."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T10:24:54Z","timestamp":1654079094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882316300016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":31,"alternative-id":["S1098882316300016"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.01.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cAssociation between platelet activating factor acetylhydrolase and diabetic retinopathy: Does inflammation affect the retinal status?\u201d","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}